How much revenue does Albert David make?

Albert David reported 3.43 billion INR in revenue for fiscal year 2025, down 4.7% from 3.60 billion INR in fiscal year 2024. In Q3 2026 revenue was 899.27 million INR.

Where does Albert David make most of its revenue?

India: 93% of revenue by region in fiscal year 2025, followed by Overseas (7%).

What companies are similar to Albert David?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Bafna Pharmaceuticals Limited (BAFNAPH.NS), Themis Medicare Limited (THEMISMED.NS), Kilitch Drugs (India) Limited (KILITCH.NS), Trident Lifeline Limited (TLL.BO).

Albert David Limited (ALBERTDAVD.NS) Stock

About Albert David Limited

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products. The company exports its products to Latin American, South East Asian and North African countries Albert David Limited was incorpora...

At a glance

Albert David reported revenue of 3.43 billion INR for fiscal year 2025, down 4.7% from fiscal year 2024, and net income of 172.01 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 899.27 million INR, up 8.2% from a year before. India was its largest region in fiscal year 2025, with 93% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.